Michael I. Greenebaum
Presidente presso Greenebaum & Rose Associates, Inc.
Profilo
Michael I.
Greenebaum is currently a Director at Profectus BioSciences, Inc., the University of Maryland School of Medicine, the Greenebaum Family Foundation, and the University of Maryland Marlene & Stewart Greenebaum Cancer.
He is also the President of Greenebaum & Rose Associates, Inc. and a Trustee at McDonogh School.
Previously, he was a Director at WellDoc, Inc.
Posizioni attive di Michael I. Greenebaum
| Società | Posizione | Inizio |
|---|---|---|
Greenebaum & Rose Associates, Inc.
 Greenebaum & Rose Associates, Inc. Real Estate DevelopmentFinance Greenebaum & Rose Associates, Inc. engages in a real estate industry. The company was founded by Stewart Greenebaum and Samuel Rose in 1981 and is headquartered in Baltimore, MD. | Presidente | - |
| Greenebaum Family Foundation | Direttore/Membro del Consiglio | - |
| McDonogh School | Direttore/Membro del Consiglio | - |
Profectus BioSciences, Inc.
 Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Direttore/Membro del Consiglio | - |
| University of Maryland School of Medicine | Direttore/Membro del Consiglio | - |
| University of Maryland Marlene & Stewart Greenebaum Cancer | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Michael I. Greenebaum
| Società | Posizione | Fine |
|---|---|---|
WellDoc, Inc.
 WellDoc, Inc. Packaged SoftwareTechnology Services WellDoc, Inc. develops technology solutions to support chronic disease management. Its product DiabetesManager provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence. The company was founded by Ryan Sysko, Yves Nordmann and Suzanne Sysko Clough in 2005 and is headquartered in Columbia, MD. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
WellDoc, Inc.
WellDoc, Inc. Packaged SoftwareTechnology Services WellDoc, Inc. develops technology solutions to support chronic disease management. Its product DiabetesManager provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence. The company was founded by Ryan Sysko, Yves Nordmann and Suzanne Sysko Clough in 2005 and is headquartered in Columbia, MD. | Technology Services |
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Health Technology |
Greenebaum & Rose Associates, Inc.
Greenebaum & Rose Associates, Inc. Real Estate DevelopmentFinance Greenebaum & Rose Associates, Inc. engages in a real estate industry. The company was founded by Stewart Greenebaum and Samuel Rose in 1981 and is headquartered in Baltimore, MD. | Finance |
| Greenebaum Family Foundation | |
| University of Maryland Marlene & Stewart Greenebaum Cancer |
- Borsa valori
- Insiders
- Michael I. Greenebaum
